Horsham, Pennsylvania — October 3, 2025 — Leads & Copy —
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) is recognizing Eczema Awareness Month by highlighting the clinical evidence supporting the XTRAC® Excimer Laser (308 nm) as a safe, effective treatment for localized atopic dermatitis, the most common form of eczema. The American Medical Association (AMA) has expanded excimer laser’s indications to inflammatory and autoimmune skin diseases, which clears the way for Medicare, Medicaid, and private payer reimbursement for atopic dermatitis treatment.
Dr. Dolev Rafeli, Strata’s CEO, said excimer laser treatment continues to capture market share among dermatologists because it remains effective, safe and durable. Healthcare providers, advocacy groups, academic key opinion leaders have advocated for it to be reimbursed across an expanded array of skin conditions, which are now being implemented across the different managed care platforms both public and private.
Atopic dermatitis affects more than 9.6 million children and 16.5 million adults in the United States. Many patients struggle with limited or ineffective treatment options, the condition severely impacts daily living, sleep, work productivity, and emotional well-being.
Dr. Mark G. Lebwohl, M.D., Dean for Clinical Therapeutics, Professor and Chairman Emeritus, Department of Dermatology, Icahn School of Medicine at Mount Sinai said the excimer laser is one of the most effective treatments for localized eczema.
Clinical trials have shown significant improvements in redness, infiltration, lichenification, and itching after four weeks of excimer therapy. Pruritus/itching intensity decreased by 81% after one month. Follow-up data confirmed Excimer Laser provided longer-lasting improvement, with histology demonstrating reduced epidermal thickness and inflammation. 69% reduction in disease severity and 70% reduction in symptom scores after ~13 sessions, 87% achieved clear or almost clear skin. Treatment was well tolerated, with only mild, sunburn-like reactions reported.
STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing, and marketing innovative products for the in-office treatment of various dermatologic conditions, such as psoriasis, vitiligo, and acne. Its products include the XTRAC® excimer laser, VTRAC® lamp systems, and the TheraClear®X Acne Therapy System.
Investor Contact:
CORE IR
516-222-2560
IR@strataskin.com
Source: STRATA Skin Sciences, Inc.
